Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse.
central nervous system
dinutuximab beta
neuroblastoma
recurrence
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 Sep 2023
25 Sep 2023
Historique:
received:
18
08
2023
revised:
15
09
2023
accepted:
18
09
2023
medline:
14
10
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
Despite highly intensive multimodality treatment regimens, the prognosis of patients with high-risk neuroblastoma (HRNB) and central nervous system (CNS) relapse remains poor. We retrospectively reviewed data from 13 patients with HRNB and CNS relapse who received multimodal therapy with consolidating haploidentical stem cell transplantation (haplo-SCT) followed by dinutuximab beta ± subcutaneous interleukin-2 (scIL-2). Following individual relapse treatment, patients aged 1-21 years underwent haplo-SCT with T/B-cell-depleted grafts followed by dinutuximab beta 20 mg/m
Identifiants
pubmed: 37834840
pii: jcm12196196
doi: 10.3390/jcm12196196
pmc: PMC10573405
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : EUSA Pharma
ID : NA
Références
Lancet Oncol. 2018 Dec;19(12):1617-1629
pubmed: 30442501
Cancer. 2003 Jul 1;98(1):155-65
pubmed: 12833468
J Clin Oncol. 2015 Sep 20;33(27):3008-17
pubmed: 26304901
J Clin Oncol. 2023 Jun 10;41(17):3135-3148
pubmed: 36854071
Am J Pathol. 2003 Aug;163(2):393-9
pubmed: 12875961
Front Pediatr. 2021 Nov 03;9:716880
pubmed: 34805033
J Neurooncol. 2010 May;97(3):409-18
pubmed: 19890606
Front Cell Dev Biol. 2021 Aug 24;9:722917
pubmed: 34504845
Pediatr Blood Cancer. 2020 Sep;67(9):e28364
pubmed: 32608559
Med Pediatr Oncol. 1996 Dec;27(6):529-33
pubmed: 8888812
N Engl J Med. 2010 Sep 30;363(14):1324-34
pubmed: 20879881
N Engl J Med. 2010 Jun 10;362(23):2202-11
pubmed: 20558371
Clin Transl Radiat Oncol. 2022 May 04;35:44-55
pubmed: 35601799
Paediatr Drugs. 2021 Nov;23(6):537-548
pubmed: 34541620
Cancer. 2001 Apr 15;91(8):1510-9
pubmed: 11301399
Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28473
pubmed: 33818884
Biol Blood Marrow Transplant. 2018 May;24(5):1005-1012
pubmed: 29307718
Pediatr Hematol Oncol. 1997 May-Jun;14(3):233-41
pubmed: 9185208
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-13
pubmed: 35522915
Radiographics. 2018 Mar-Apr;38(2):566-580
pubmed: 29528815
Bone Marrow Transplant. 2006 Feb;37(3):271-6
pubmed: 16400336
Cancer. 2017 Apr 1;123(7):1095-1105
pubmed: 27984660
J Clin Med. 2023 Aug 11;12(16):
pubmed: 37629294
Transl Lung Cancer Res. 2021 Apr;10(4):2032-2047
pubmed: 34012812
Eur J Cancer. 2021 Feb;144:1-8
pubmed: 33316634
Bone Marrow Transplant. 2022 Mar;57(3):423-430
pubmed: 34952929
J Clin Oncol. 2005 May 20;23(15):3447-54
pubmed: 15753458